Globe Life Inc. is an insurance holding company. Co.'s primary subsidiaries are Globe Life And Accident Insurance Co., American Income Life Insurance Co., Liberty National Life Insurance Co., Family Heritage Life Insurance Co. of America, and United American Insurance Co.. Co. offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, and intensive care products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program.
When researching a stock like Globe Life, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from GL Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for GL stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the GL 200 day moving average ("GL 200 DMA"), while one of the most popular "shorter look-backs" is the GL 50 day moving average ("GL 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Globe Life. Comparing two moving averages against each other can be a useful visualization tool: by calculating the difference between the GL 200 DMA and the GL 50 DMA, we get a moving average convergence divergence indicator ("GL MACD"). The GL MACD chart, in conjunction with the chart of the moving averages, basically helps in visualizing how the moving averages are showing convergence (moving closer together), or divergence (moving farther apart). |